Cosmos Health Inc (COSM)

$0.24 +0.04 (17.61%)
Market Cap 14.72M
Revenue (ttm) 65.27M
Net Income (ttm) -19.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.34%
Debt to Equity Ratio 0.46
Volume 18,865,799
Avg Vol 7,741,604
Day's Range N/A - N/A
Shares Out 62.08M
Stochastic %K 89%
Beta 4.83
Analysts Strong Buy
Price Target $4.50

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogre...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece
Stopcryin
Stopcryin Jul. 4 at 6:34 PM
$COSM .23 ... no longer .27
1 · Reply
Stopcryin
Stopcryin Jul. 4 at 5:50 PM
$COSM Down 8% overseas from the highs!
1 · Reply
BigSwingingDuck
BigSwingingDuck Jul. 4 at 5:50 PM
$COSM
0 · Reply
bjhbj
bjhbj Jul. 4 at 2:48 AM
$COSM
0 · Reply
BadensBester
BadensBester Jul. 3 at 9:13 PM
$COSM +25% in Germany today
1 · Reply
topstockalerts
topstockalerts Jul. 3 at 8:05 PM
$COSM this move feels more organized than most
0 · Reply
William_H_Bonney
William_H_Bonney Jul. 3 at 3:55 PM
$COSM are we changing targets now when the OS will be reduced?
0 · Reply
Stopcryin
Stopcryin Jul. 3 at 12:40 PM
$COSM This guy disappeared 🦗🦗 once this stock tanked and his prediction took a dump. Now be's back after this has a good day? topstockalerts Jul 2 $COSM that response was stronger than most would have guessed.
0 · Reply
Cataclismous
Cataclismous Jul. 3 at 12:28 PM
$COSM
0 · Reply
BananaBrawler
BananaBrawler Jul. 3 at 11:09 AM
$COSM
0 · Reply
Latest News on COSM
Cosmos Health expands buyback with additional 770,000 share repurchase

2026-07-02T18:15:08.000Z - 2 days ago

Cosmos Health expands buyback with additional 770,000 share repurchase

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Jul 2, 2026, 2:10 PM EDT - 2 days ago

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Jul 1, 2026, 11:05 AM EDT - 3 days ago

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Cosmos Health authorizes up to $5M share repurchase program

2026-06-30T16:00:32.000Z - 4 days ago

Cosmos Health authorizes up to $5M share repurchase program

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Jun 30, 2026, 11:55 AM EDT - 4 days ago

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Cosmos Health signs distribution agreement with IMC

2026-06-26T16:35:09.000Z - 8 days ago

Cosmos Health signs distribution agreement with IMC

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Jun 26, 2026, 12:30 PM EDT - 8 days ago

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Cosmos Health’s Cana advances international patent application

2026-06-25T19:40:17.000Z - 9 days ago

Cosmos Health’s Cana advances international patent application

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Jun 25, 2026, 3:31 PM EDT - 9 days ago

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Jun 24, 2026, 3:37 PM EDT - 10 days ago

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Cosmos Health to deploy AI-powered call center

2026-06-23T19:40:11.000Z - 11 days ago

Cosmos Health to deploy AI-powered call center

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Jun 23, 2026, 3:35 PM EDT - 11 days ago

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Cosmos Health builds contract manufacturing orderbook to over 25M units

2026-06-22T14:40:08.000Z - 12 days ago

Cosmos Health builds contract manufacturing orderbook to over 25M units

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

Jun 22, 2026, 10:30 AM EDT - 12 days ago

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Jun 18, 2026, 3:34 PM EDT - 16 days ago

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Jun 17, 2026, 3:35 PM EDT - 17 days ago

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Jun 17, 2026, 9:27 AM EDT - 17 days ago

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Jun 15, 2026, 9:00 AM EDT - 19 days ago

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

2026-06-12T19:40:29.000Z - 22 days ago

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Jun 12, 2026, 3:33 PM EDT - 22 days ago

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Jun 12, 2026, 9:29 AM EDT - 22 days ago

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Cosmos Health to acquire Doc Pharma, terms undisclosed

2026-06-11T19:35:09.000Z - 23 days ago

Cosmos Health to acquire Doc Pharma, terms undisclosed

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Jun 11, 2026, 3:31 PM EDT - 23 days ago

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Cosmos Health secures 180-day extension to regain Nasdaq compliance

2026-06-11T13:44:08.000Z - 23 days ago

Cosmos Health secures 180-day extension to regain Nasdaq compliance

Cosmos Health unit signs three-year contract with Verisfield

2026-06-10T19:35:08.000Z - 24 days ago

Cosmos Health unit signs three-year contract with Verisfield

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Jun 10, 2026, 3:32 PM EDT - 24 days ago

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Jun 10, 2026, 9:00 AM EDT - 24 days ago

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Cosmos Health unit wins contract manufacturing agreement with Provident Pharma

2026-06-09T19:35:10.000Z - 25 days ago

Cosmos Health unit wins contract manufacturing agreement with Provident Pharma

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Jun 9, 2026, 3:30 PM EDT - 25 days ago

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Cosmos subsidiary acquires ownership of patent application from Cloudpharm

2026-06-08T14:06:31.000Z - 26 days ago

Cosmos subsidiary acquires ownership of patent application from Cloudpharm

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Jun 8, 2026, 10:00 AM EDT - 26 days ago

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Jun 5, 2026, 9:25 AM EDT - 4 weeks ago

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Jun 4, 2026, 3:57 PM EDT - 4 weeks ago

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Cosmos Health explores monetization of non-core assets

2026-06-04T13:31:09.000Z - 4 weeks ago

Cosmos Health explores monetization of non-core assets

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Jun 4, 2026, 9:25 AM EDT - 4 weeks ago

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Jun 1, 2026, 8:25 AM EDT - 4 weeks ago

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Cosmos Health says targeting $200M in revenue by 2029

2026-05-26T16:44:56.000Z - 5 weeks ago

Cosmos Health says targeting $200M in revenue by 2029

Cosmos Health sees FY26 revenue surpassing $90M, one est. $87.3M

2026-05-26T16:44:16.000Z - 5 weeks ago

Cosmos Health sees FY26 revenue surpassing $90M, one est. $87.3M

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

May 26, 2026, 9:34 AM EDT - 5 weeks ago

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026, 2:20 PM EDT - 6 weeks ago

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

Cosmos Health reports Q1 revenue $17.93M vs $13.71M last year

2026-05-21T13:26:56.000Z - 6 weeks ago

Cosmos Health reports Q1 revenue $17.93M vs $13.71M last year

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

May 21, 2026, 9:15 AM EDT - 6 weeks ago

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

Cosmos Health pursues research, development financing program with EIB

2026-05-14T14:14:59.000Z - 7 weeks ago

Cosmos Health pursues research, development financing program with EIB

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 14, 2026, 9:00 AM EDT - 7 weeks ago

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

Cosmos Health announces withdrawal of registration statement on Form S-1

2026-05-12T18:46:06.000Z - 7 weeks ago

Cosmos Health announces withdrawal of registration statement on Form S-1

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 12, 2026, 10:15 AM EDT - 7 weeks ago

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 11, 2026, 2:25 PM EDT - 7 weeks ago

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 8, 2026, 11:25 AM EDT - 2 months ago

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

Cosmos Health sees over $2.5M incremental annual revenue from Cur18 in U.S.

2026-04-30T17:37:57.000Z - 2 months ago

Cosmos Health sees over $2.5M incremental annual revenue from Cur18 in U.S.

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Apr 30, 2026, 12:50 PM EDT - 2 months ago

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Apr 21, 2026, 12:50 PM EDT - 2 months ago

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Apr 20, 2026, 10:55 AM EDT - 2 months ago

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Cosmos Health announces planned U.S. market launch of Cur18b

2026-04-17T18:05:11.000Z - 2 months ago

Cosmos Health announces planned U.S. market launch of Cur18b

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Apr 17, 2026, 2:00 PM EDT - 2 months ago

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Apr 16, 2026, 3:15 PM EDT - 2 months ago

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Apr 15, 2026, 9:25 AM EDT - 2 months ago

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

Apr 13, 2026, 12:50 PM EDT - 2 months ago

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

Apr 10, 2026, 9:40 AM EDT - 3 months ago

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

Apr 8, 2026, 11:10 AM EDT - 3 months ago

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

Apr 1, 2026, 11:42 AM EDT - 3 months ago

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

Mar 19, 2026, 12:45 PM EDT - 3 months ago

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000

Mar 11, 2026, 1:45 PM EDT - 4 months ago

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

Feb 24, 2026, 12:30 PM EST - 4 months ago

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value

Feb 19, 2026, 11:30 AM EST - 4 months ago

Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value

Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer

Feb 18, 2026, 1:45 PM EST - 4 months ago

Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer

Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer

Feb 18, 2026, 10:17 AM EST - 4 months ago

Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026

Feb 17, 2026, 11:25 AM EST - 4 months ago

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

Feb 11, 2026, 12:10 PM EST - 5 months ago

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

Jan 20, 2026, 10:45 AM EST - 5 months ago

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

Stopcryin
Stopcryin Jul. 4 at 6:34 PM
$COSM .23 ... no longer .27
1 · Reply
Stopcryin
Stopcryin Jul. 4 at 5:50 PM
$COSM Down 8% overseas from the highs!
1 · Reply
BigSwingingDuck
BigSwingingDuck Jul. 4 at 5:50 PM
$COSM
0 · Reply
bjhbj
bjhbj Jul. 4 at 2:48 AM
$COSM
0 · Reply
BadensBester
BadensBester Jul. 3 at 9:13 PM
$COSM +25% in Germany today
1 · Reply
topstockalerts
topstockalerts Jul. 3 at 8:05 PM
$COSM this move feels more organized than most
0 · Reply
William_H_Bonney
William_H_Bonney Jul. 3 at 3:55 PM
$COSM are we changing targets now when the OS will be reduced?
0 · Reply
Stopcryin
Stopcryin Jul. 3 at 12:40 PM
$COSM This guy disappeared 🦗🦗 once this stock tanked and his prediction took a dump. Now be's back after this has a good day? topstockalerts Jul 2 $COSM that response was stronger than most would have guessed.
0 · Reply
Cataclismous
Cataclismous Jul. 3 at 12:28 PM
$COSM
0 · Reply
BananaBrawler
BananaBrawler Jul. 3 at 11:09 AM
$COSM
0 · Reply
Daniel_2025
Daniel_2025 Jul. 3 at 6:56 AM
$COSM why are they buying back share. At what purpose. Is this to try an reach minimum price. ?
1 · Reply
kalbany
kalbany Jul. 3 at 2:58 AM
$COSM for the confused souls - they’re buying back $5 million worth of shares and at .20 that’s roughly 25 million shares
1 · Reply
kalbany
kalbany Jul. 3 at 2:51 AM
$COSM looking good here
0 · Reply
BockwurstGC
BockwurstGC Jul. 3 at 2:47 AM
$COSM
1 · Reply
BelbeckBoy
BelbeckBoy Jul. 3 at 2:17 AM
$COSM 3 mill worth of buying YET TO COME by corporate. Next week we see .45 early! Buckle up.
1 · Reply
Kid_Shelleen
Kid_Shelleen Jul. 3 at 1:58 AM
$COSM It was the scaredy pants small frys selling, that's all.
0 · Reply
DonDeutsch
DonDeutsch Jul. 3 at 1:41 AM
$COSM Monday...
0 · Reply
BananaBrawler
BananaBrawler Jul. 3 at 1:25 AM
$COSM great close today
0 · Reply
bjhbj
bjhbj Jul. 3 at 12:58 AM
$COSM lol
0 · Reply
MOOSEN
MOOSEN Jul. 2 at 11:45 PM
$COSM BEEN A WHILE…BACK IN-PLAY?
0 · Reply
Shibhan_Yolo
Shibhan_Yolo Jul. 2 at 11:41 PM
$COSM I remember my first day trading too.
1 · Reply
Stopcryin
Stopcryin Jul. 2 at 11:27 PM
$COSM Now look 😆🤣😆
1 · Reply